Literature DB >> 19559347

Use of a saline chaser in abdominal computed tomography: a systematic review.

Hidemasa Takao1, Takeshi Nojo, Kuni Ohtomo.   

Abstract

PURPOSE: To perform a systematic review of the literature regarding the use of a saline chaser in abdominal computed tomography (CT).
MATERIALS AND METHODS: The MEDLINE database was searched from 1966 to March 2007. Studies were included if they compared the magnitude of contrast enhancement with and without a saline chaser in CT and reported CT contrast enhancement values of the liver, portal vein, or abdominal aorta. For randomized controlled trials (RCTs) comparing the same dose of contrast material with and without a saline chaser, mean differences in the magnitude of contrast enhancement were pooled by using a fixed-effects model.
RESULTS: Seventeen studies met the inclusion criteria. Three RCTs using clinical images were included in the meta-analysis. The mean differences in contrast enhancement of the liver, portal vein, and aorta were -0.4 (95% CI, -2.4 to 1.7), 7.4 (95% CI, 1.3 to 14), and 11 (95% CI, -5.3 to 27), respectively. Three RCTs using a time-density analysis were included in the meta-analysis. The mean differences in peak contrast enhancement of the liver, portal vein, and aorta were 8.2 (95% CI, 4.2 to 12), 28 (95% CI, 16 to 40), and 15 (95% CI, 0.3 to 30), respectively.
CONCLUSION: In clinical images, a saline chaser did not improve contrast enhancement of the liver. In time-density analysis, however, a saline chaser improved peak contrast enhancement of the liver.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19559347     DOI: 10.1016/j.clinimag.2008.10.032

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  1 in total

1.  64-section multidetector CT of the upper abdomen: optimization of a saline chaser injection protocol for improved vascular and parenchymal contrast enhancement.

Authors:  Daniele Marin; Rendon C Nelson; Antonino Guerrisi; Huiman Barnhart; Sebastian T Schindera; Roberto Passariello; Carlo Catalano
Journal:  Eur Radiol       Date:  2011-05-11       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.